阻断CCN2可减少长期强度负荷诱导的已建立的骨损失,通过增加大鼠骨质母细胞活动来减少这种损失
Alex G Lambi1, Michele Y Harris2, Mamta Amin2
1Department of Orthopedics and Rehabilitation University of New Mexico Albuquerque NM USA.
JBMR plus
|September 13, 2023
概括
高重复性,高强度的任务会导致有害的骨重塑. 在休息期间用抗CCN2治疗改善了骨密度和骨质形成,这表明其对过度使用引起的骨损失的治疗潜力.
科学领域:
- 骨生物学和重塑骨的方法
- 骨生理学 骨生理学
- 生物医学研究生物医学研究
背景情况:
- 重复重复的高力任务可能导致有害的骨重塑,特别是骨质疏松症,而不是有益的适应.
- 了解这种骨损失背后的机制对于开发有效干预措施至关重要.
研究的目的:
- 研究抗CCN2 (FG-3019) 的治疗潜力,以减轻长期高重复性,高强度 (HRHF) 任务引起的骨损失.
- 为了比较抗CCN2治疗在休息期间与IgG控制和不治疗的效果.
主要方法:
- 成年雌性Sprague-Dawley大鼠接受了为期18周的HRHF任务,诱导放射性椎骨骨质疏松症.
- 任务结束后,大鼠休息了6周,同时接受了抗CCN2或控制IgG的同时治疗.
- 微计算机断层扫描 (MicroCT) 和组织形态测量用于分析骨结构,骨质细胞和骨质细胞活动以及矿物化.
主要成果:
- HRHF任务导致椎骨体积分数和厚度下降.
- 与未经治疗和IgG组相比,休息期间的抗CCN2治疗显著改善了骨体积分数,厚度,骨质母细胞数,矿化和骨形成率.
- 两种疗法都改善了骨体积,减少了骨质细胞数量,但抗CCN2对骨形成标志物表现出更好的效果.
结论:
- 长期的高重复性,高强度的任务会诱导负面的骨重塑和骨质疏松症.
- 在康复期间的抗CCN2治疗有效地逆转了任务诱导的骨损失,并促进了骨的形成.
- 抗CCN2是一种有前途的治疗药物,用于治疗与慢性过度使用损伤相关的骨质损失.
相关概念视频
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
Role of Vitamins in Maintaining Bone Health
3.4K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.4K


